Literature DB >> 11281472

The effect of stopping smoking on cervical Langerhans' cells and lymphocytes.

A Szarewski1, P Maddox, P Royston, M Jarvis, M Anderson, J Guillebaud, J Cuzick.   

Abstract

OBJECTIVE: To investigate the effects of stopping smoking on cervical Langerhans' cells and lymphocytes.
DESIGN: Prospective intervention study.
SETTING: A large family planning clinic in central London. POPULATION: Women volunteers prepared to attempt to give up smoking for six months. Their most recent cervical smear showed no abnormality greater than mild dyskaryosis.
METHODS: The women were seen at three-month intervals for six months. Reduction in smoking was assessed by self-reporting and validated by salivary cotinine concentrations. Colposcopy and a biopsy of a normal area were performed at the first and last visits. Any area of abnormality was also biopsied at the final visit. Langerhans' cells and lymphocytes were counted. MAIN OUTCOME MEASURES: Proportional changes in counts of Langerhans' cells and lymphocytes with reduction in smoking.
RESULTS: Reduction in smoking by 20 to 40 cigarettes per day was significantly associated with a reduction of between 6% and 16% in counts of Langerhans cells, CD8 and total lymphocytes. Heavy smoking was significantly associated (P = 0.02) with an increased chance of persistent human papillomavirus infection. The presence of candida was associated with significantly higher counts of between 41% and 47% in total lymphocytes and CD8 lymphocytes. In contrast, the presence of anaerobic vaginosis was associated with significantly lower counts of between 16% and 30% in Langerhans cells, CD4 and CD8 lymphocytes.
CONCLUSIONS: This large intervention study has demonstrated a clear relationship between reduction in smoking and changes in cervical immune cell counts. Future studies need to take into account cytokine interactions, which recent studies suggest may be significant in the immune response to both human papillomavirus and cervical intraepithelial neoplasia and the ever-increasing complexity of the cell-mediated immune system of the cervix.

Entities:  

Mesh:

Year:  2001        PMID: 11281472     DOI: 10.1111/j.1471-0528.2001.00074.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  9 in total

1.  Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype.

Authors:  Cornelia L Trimble; Steven Piantadosi; Patti Gravitt; Brigitte Ronnett; Ellen Pizer; Andrea Elko; Barbara Wilgus; William Yutzy; Richard Daniel; Keerti Shah; Shiwen Peng; Chienfu Hung; Richard Roden; Tzyy Choou Wu; Drew Pardoll
Journal:  Clin Cancer Res       Date:  2005-07-01       Impact factor: 12.531

2.  Active and passive cigarette smoking and the risk of cervical neoplasia.

Authors:  Cornelia L Trimble; Jeanine M Genkinger; Alyce E Burke; Sandra C Hoffman; Kathy J Helzlsouer; Marie Diener-West; George W Comstock; Anthony J Alberg
Journal:  Obstet Gynecol       Date:  2005-01       Impact factor: 7.661

3.  Relationship between cigarette smoking and human papilloma virus types 16 and 18 DNA load.

Authors:  Long Fu Xi; Laura A Koutsky; Philip E Castle; Zoe R Edelstein; Craig Meyers; Jesse Ho; Mark Schiffman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

4.  Polycyclic aromatic hydrocarbon-DNA adducts in cervix of women infected with carcinogenic human papillomavirus types: an immunohistochemistry study.

Authors:  M Margaret Pratt; Paul Sirajuddin; Miriam C Poirier; Mark Schiffman; Andrew G Glass; David R Scott; Brenda B Rush; Ofelia A Olivero; Philip E Castle
Journal:  Mutat Res       Date:  2007-05-05       Impact factor: 2.433

5.  Development of biomarker panel to predict, prevent and create treatments tailored to the persons with human papillomavirus-induced cervical precancerous lesions.

Authors:  Liudmyla M Lazarenko; Olena E Nikitina; Evgen V Nikitin; Olga M Demchenko; Galyna V Kovtonyuk; Larysa O Ganova; Rostyslav V Bubnov; Veronika O Shevchuk; Natalia M Nastradina; Viktoria V Bila; Mykola Ya Spivak
Journal:  EPMA J       Date:  2014-01-06       Impact factor: 6.543

6.  Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study.

Authors:  S Rachel Skinner; Cosette M Wheeler; Barbara Romanowski; Xavier Castellsagué; Eduardo Lazcano-Ponce; M Rowena Del Rosario-Raymundo; Carlos Vallejos; Galina Minkina; Daniel Pereira Da Silva; Shelly McNeil; Vera Prilepskaya; Irina Gogotadze; Deborah Money; Suzanne M Garland; Viktor Romanenko; Diane M Harper; Myron J Levin; Archana Chatterjee; Brecht Geeraerts; Frank Struyf; Gary Dubin; Marie-Cécile Bozonnat; Dominique Rosillon; Laurence Baril
Journal:  Int J Cancer       Date:  2016-05-15       Impact factor: 7.396

7.  Tobacco Exposure Enhances Human Papillomavirus 16 Oncogene Expression via EGFR/PI3K/Akt/c-Jun Signaling Pathway in Cervical Cancer Cells.

Authors:  Juan P Muñoz; Diego Carrillo-Beltrán; Víctor Aedo-Aguilera; Gloria M Calaf; Oscar León; Edio Maldonado; Julio C Tapia; Enrique Boccardo; Michelle A Ozbun; Francisco Aguayo
Journal:  Front Microbiol       Date:  2018-12-17       Impact factor: 5.640

8.  Infiltrating T-cell markers in cervical carcinogenesis: a systematic review and meta-analysis.

Authors:  Tamara R Litwin; Sarah R Irvin; Rebecca L Chornock; Vikrant V Sahasrabuddhe; Margaret Stanley; Nicolas Wentzensen
Journal:  Br J Cancer       Date:  2020-12-01       Impact factor: 7.640

9.  Impact of smoking on the quantity and quality of antibodies induced by human papillomavirus type 16 and 18 AS04-adjuvanted virus-like-particle vaccine - a pilot study.

Authors:  Proscovia B Namujju; Emma Pajunen; Aline Simen-Kapeu; Lea Hedman; Marko Merikukka; Helja-Marja Surcel; Reinhard Kirnbauer; Dan Apter; Jorma Paavonen; Klaus Hedman; Matti Lehtinen
Journal:  BMC Res Notes       Date:  2014-07-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.